Literature DB >> 3721293

Use of alpha-tocopherylquinone in the treatment of ulcerative colitis.

J D Bennet.   

Abstract

The effect of alpha-tocopherylquinone (alpha-TQ) and a low fat diet on a patient with chronic continuous ulcerative colitis was described. The patient's condition improved dramatically with both colonic and extraintestinal manifestations of the disease greatly reduced with doses of alpha-TQ of 3.0 g/day (50 mg/kg/d) or greater. Withdrawal of alpha-TQ for periods of one to two days produced recurrence of inflammation which was again reduced upon re-introduction of alpha-TQ.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3721293      PMCID： PMC1433321          DOI： 10.1136/gut.27.6.695

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  6 in total

1.  Alpha-tocohydroquinone and muscle dystrophy.

Authors:  P L HARRIS; K E MASON
Journal:  Am J Clin Nutr       Date:  1956 Jul-Aug       Impact factor: 7.045

2.  Antisterility and antivitamin K activity of d-alpha-tocopheryl hydroquinone in the vitamin E-deficient female rat.

Authors:  G H Rao; K E Mason
Journal:  J Nutr       Date:  1975-04       Impact factor: 4.798

3.  A controlled trial of azathioprine in the management of chronic ulcerative colitis.

Authors:  J L Rosenberg; A J Wall; B Levin; H J Binder; J B Kirsner
Journal:  Gastroenterology       Date:  1975-07       Impact factor: 22.682

Review 4.  Vitamin E: a reexamination.

Authors:  M K Horwitt
Journal:  Am J Clin Nutr       Date:  1976-05       Impact factor: 7.045

5.  Azathioprine in ulcerative colitis: final report on controlled therapeutic trial.

Authors:  D P Jewell; S C Truelove
Journal:  Br Med J       Date:  1974-12-14

6.  Controlled trial of azathioprine in chronic ulcerative colitis.

Authors:  A P Kirk; J E Lennard-Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-01
  6 in total
  1 in total

1.  Use of alpha-tocopherylquinone in ulcerative colitis.

Authors:  E Guthy
Journal:  Gut       Date:  1986-11       Impact factor: 23.059
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.